 REHOVOT, Israel, Dec. 21, 2020 GLOBE NEWSWIRE -- Kamada Ltd. NASDAQ: KMDA; TASE: KMDA.TA, a plasma-derived biopharmaceutical company, today announced that it has been selected for addition to the NASDAQ Biotechnology Index Nasdaq: NBI. The annual re-ranking of the NASDAQ Biotechnology Index will become effective prior to market open on Monday, December 21, 2020. 